Lamberts SW - Search Results

1

Type I interferons in the treatment of pancreatic cancer: mechanisms of action and role of related receptors.

Vitale G, van Eijck CH, van Koetsveld Ing PM, Erdmann JI, Speel EJ, van der Wansem Ing K, Mooij DM, Colao A, Lombardi G, Croze E, Lamberts SW, Hofland LJ. Vitale G, et al. Among authors: lamberts sw. Ann Surg. 2007 Aug;246(2):259-68. doi: 10.1097/01.sla.0000261460.07110.f2. Ann Surg. 2007. PMID: 17667505 Free PMC article.

2

IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro.

Vitale G, de Herder WW, van Koetsveld PM, Waaijers M, Schoordijk W, Croze E, Colao A, Lamberts SW, Hofland LJ. Vitale G, et al. Among authors: lamberts sw. Cancer Res. 2006 Jan 1;66(1):554-62. doi: 10.1158/0008-5472.CAN-05-3043. Cancer Res. 2006. PMID: 16397272

3

Potent inhibitory effects of type I interferons on human adrenocortical carcinoma cell growth.

van Koetsveld PM, Vitale G, de Herder WW, Feelders RA, van der Wansem K, Waaijers M, van Eijck CH, Speel EJ, Croze E, van der Lely AJ, Lamberts SW, Hofland LJ. van Koetsveld PM, et al. Among authors: lamberts sw. J Clin Endocrinol Metab. 2006 Nov;91(11):4537-43. doi: 10.1210/jc.2006-0620. Epub 2006 Aug 15. J Clin Endocrinol Metab. 2006. PMID: 16912135

4

Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.

Vitale G, van Koetsveld PM, de Herder WW, van der Wansem K, Janssen JA, Colao A, Lombardi G, Lamberts SW, Hofland LJ. Vitale G, et al. Among authors: lamberts sw. Am J Physiol Endocrinol Metab. 2009 Mar;296(3):E559-66. doi: 10.1152/ajpendo.90770.2008. Epub 2009 Jan 13. Am J Physiol Endocrinol Metab. 2009. PMID: 19141687 Free article.

5

Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system.

Dalm VA, van Hagen PM, van Koetsveld PM, Langerak AW, van der Lely AJ, Lamberts SW, Hofland LJ. Dalm VA, et al. Among authors: lamberts sw. J Clin Endocrinol Metab. 2003 Jan;88(1):270-6. doi: 10.1210/jc.2002-020950. J Clin Endocrinol Metab. 2003. PMID: 12519865 Free article.

6

Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours.

de Herder WW, Hofland LJ, van der Lely AJ, Lamberts SW. de Herder WW, et al. Among authors: lamberts sw. Endocr Relat Cancer. 2003 Dec;10(4):451-8. doi: 10.1677/erc.0.0100451. Endocr Relat Cancer. 2003. PMID: 14713257 Review.

7

Somatostatin analogs in the diagnosis and treatment of cancer.

Lamberts SW, de Herder WW, Hofland LJ. Lamberts SW, et al. Trends Endocrinol Metab. 2002 Dec;13(10):451-7. doi: 10.1016/s1043-2760(02)00667-7. Trends Endocrinol Metab. 2002. PMID: 12431842 Review.

8

The pathophysiological consequences of somatostatin receptor internalization and resistance.

Hofland LJ, Lamberts SW. Hofland LJ, et al. Among authors: lamberts sw. Endocr Rev. 2003 Feb;24(1):28-47. doi: 10.1210/er.2000-0001. Endocr Rev. 2003. PMID: 12588807 Free article. Review.

9

Differential expression of somatostatin receptor subtypes in human peripheral blood mononuclear cell subsets.

Lichtenauer-Kaligis EG, Dalm VA, Oomen SP, Mooij DM, van Hagen PM, Lamberts SW, Hofland LJ. Lichtenauer-Kaligis EG, et al. Among authors: lamberts sw. Eur J Endocrinol. 2004 Apr;150(4):565-77. doi: 10.1530/eje.0.1500565. Eur J Endocrinol. 2004. PMID: 15080788

10

Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissues.

Dalm VA, Van Hagen PM, de Krijger RR, Kros JM, Van Koetsveld PM, Van Der Lely AJ, Lamberts SW, Hofland LJ. Dalm VA, et al. Among authors: lamberts sw. Clin Endocrinol (Oxf). 2004 May;60(5):625-9. doi: 10.1111/j.1365-2265.2004.02024.x. Clin Endocrinol (Oxf). 2004. PMID: 15104567

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

732 results

Search Page